A specific monoclonal antibody for Escherichia coli and Shigella sp. alkaline phosphatase was used in an immunocapture assay and allowed identification of E. coli either in culture isolates or directly in clinical specimens. The assay was easy and required only four steps: (i) alkaline phosphatase was released within 10 min by using a gentle lysis procedure, (ii) cell lysates were transferred to antibody-coated tubes for 45 min, (iii) p-nitrophenyl phosphate substrate was added, and (iv) alkaline phosphatase activity was detected in a microsample spectrophotometer at 410 nm. This immunocapture assay was highly specific: only one false-positive reaction was observed with a Klebsiella pneumoniae lysate among the 205 non-E. coli strains tested. The assay was sensitive, detecting 107 CFU/ml from culture isolates or 105 CFU/ml from urine specimens which had first been grown in phosphate-limiting medium for 2 h. At these bacterial concentrations, the percentages of detected E. coli were high: 91% for blood cultures, 95.4% for culture isolates, and 96.8% for urine specimens.
Escherichia coli is frequently a human pathogen. It causes 75 to 90% of community-acquired acute urinary tract infections and is the most common etiological agent of nosocomial urinary tract infections and primary bacteremias (8, 26) . A rapid and direct system for the identification of E. coli is thus of clinical relevance. Recently, we described a monoclonal antibody (MAb) specific for E. coli and Shigella species alkaline phosphatase (9, 10) . This enzymic protein, a dimer of two identical subunits (23) , is localized in the periplasmic space and at the cell surface of the gramnegative cell envelope in association with lipopolysaccharides (2, 16, 17) . Its synthesis is strongly and immediately derepressed under phosphate-limiting conditions (7, 22) . This antigen and our MAb were candidates for an antibodybased in vitro diagnostic assay. However, to be useful in a clinical setting, the assay must be quick, easy to interpret, and adaptable to current technology. The purpose of this paper is to describe an enzyme capture assay that uses our MAb and accurately detects E. coli either in culture isolates or directly in urine and blood specimens.
MATERIALS AND METHODS
Bacterial strains and growth conditions. A total of 186 Lille hospital clinical isolates was studied (Table 1) . Before being tested, al isolates were grown in brain heart infusion broth and then subcultured on a MacConkey agar plate to ensure purity and viability. The final identification was obtained by using tables in Bergey's Mantual oflSysteinatic Bac teriology (14, 19) .
Clinical specimens. Fresh urine specimens sent to the hospital laboratory were examined. Each sample was filtered through sterile paper to eliminate cellular fragments and centrifuged at 4,000 x g for 10 min. The pellet was washed once with an equal volume of sterile distilled water before being grown in 5 ml of a phosphate-limiting medium (7) in a rotary shaker-incubator at 150 rpm. After 2 h of incubation at * Corresponding author. 37°C, the suspension was centrifuged (4,000 x g for 10 min) and the pellet was lysed as described below. Each specimen was also cultured on MacConkey agar plates by a standard procedure (3), and after an overnight incubation, the organisms were counted and identified.
Blood samples (5 ml) were aseptically removed from positive BACTEC NR 660 bottles and placed into sterile tubes. The tubes were centrifuged at low speed (150 x g) for 10 min. Turbid supernatants were decanted into a sterile tube and centrifuged at high speed (1,500 x g) for 10 min. The pellets were lysed as described below and isolated on sheep blood and MacConkey agar plates.
MAb production. Specific MAb was obtained from fusion of SP,0/Ag-14 myeloma cells and spleen cells from a mouse immunized with purified alkaline phosphatase of E. coli ATCC 10536, as described elsewhere (9 Alkaline phosphatase-specific binding by our MAb in an E. coli alkaline phosphatase immunocapture assay is summarized in Table 1 . The 62 E. coli isolates and 6 S/hige/ll strains which produced the corresponding enzyme gave a positive reaction. No positive reactions were observed among the 114 other gram-negative bacilli tested. The sensitivity of the test was evaluated by using suspensions of different concentrations. When bacterial strains were grown on MacConkey agar, a positive reaction was observed for 107 cells per ml. If bacterial strains were grown in a phosphate-limiting medium to derepress alkaline phosphatase synthesis, as described by Garen and Levinthal (7) , this sensitivity was 10-to 100-fold higher.
APa was found in cell lysates prepared from urine specimens infected with E. cali (95.4c), other Enterobacteriaceae (40 to 87%c), and P. aceruginosa isolates (100%7) ( 
DISCUSSION
In this paper we describe a rapid and economical tool for identifying E. coli that is based on an alkaline phosphatase enzyme immunocapture assay. For this test, a MAb specific for E. aoli alkaline phosphatase (9, 10) was applied to polystyrene tubes; the captured enzyme was directly revealed by addition of the substrate (p-nitrophenyl phosphate) instead of a second antienzyme antibody. This assay was easy to perform and could be completed within 70 min when we used bacterial strains isolated on MacConkey agar. For urine specimens. a short 2-h culture in a phosphatelimiting medium was necessary prior to the assay. The culture improved the secretion of alkaline phosphatase by increasing the concentration of bacterial cells and by derepressing alkaline phosphatase synthesis. With conventional blood culture systems, initial evidence of growth had to be determined by visual inspection or examination with the BACTEC system followed by Gram staining to identify the presence of a gram-negative rod. When gram-negative bacteria were present, the E. coli alkaline phosphatase immunocapture assay was able to rapidly identify E. cali. The time required for this assay was short: 10 min to lyse cells, 45 min for incubation of cell lysate in antibody-coated tubes, and 15 min for alkaline phosphatase detection. This test, like enzyme-linked immunosorbent assays, could be automated, thereby reducing many measurement times. VOL. 27. 1989) This enzyme capture procedure was specific: only one false-positive reaction was observed with a K. pneuinoniae lysate (prepared from a urine specimen) among the 205 other isolates of the Enterobacteriaceae tested. A cross-reaction was observed with E. coli and Shigella sp. isolated on MacConkey agar. However, Shigella strains are very rarely present in blood or urine culture and are generally different from E. coli in their production of 3-galactosidase. The other species of the genus Escherichia, other than E. coli, are negative for the reaction with our MAb (10) . Consequently, they were not studied in this developmental stage. The enzyme capture procedure was sensitive because it detected 107 CFU/ml from culture isolates or 105 CFU/ml from urine specimens which were first grown in phosphate-limiting medium. Recent studies (12, 20) have focused on significant bacteriuria in patients other than asymptomatic females in whom concentrations less than 105 CFU/ml were significant and associated with true bacteriuria. Even though it was well understood that in these patients bacteriuria might be evidenced by as few as 102 microorganisms, the sensitivity of our procedure was comparable to that of many urinescreening systems which detect bacteriuria of 105 CFU/ml or more (18, 25) . At these bacterial concentrations, the percentage of E. coli strains detected by our system was high: 917i for blood cultures, 96.8% for culture isolates, and 95.4% for urine specimens. The lack of production of alkaline phosphatase by a few E. coli strains explains these false-negative reactions.
Most other biochemical procedures proposed for a rapid diagnosis of E. coli use the detection of P-glucuronidase activity, which is specific for the genera Escherichia, Shigella, and Salmonella (13) . This enzyme is detected alone (6, 24) or in association with P-galactosidase and indole production (4, 5). These assay procedures are rapid (1 to 2 h), specific (95 to 100%), and sensitive (93 to 97% of E. coli producing P-glucuronidase; 4, 13 (15) , counterimmunoelectrophoresis (1), or radioimmunoassay (21) with antiserum induced with group B N. meningitidis organisms.
In conclusion, the test described is highly sensitive and specific for the detection of E. coli. The identification is easy and rapid (70 min) and may be performed with culture isolates, blood culture, or short culture (2 h) of urine specimens. It allows specific antimicrobial treatment 24 h before other commonly used systems. The test could be automated, and its cost could be very low. However, it is clear that this work is still in the developmental stage, and a double-blind study or multicenter work will need to be done in the future.
